Pub. Date : 2016 Mar
PMID : 26846322
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Selexipag (Uptravi( )) is a highly selective, long-acting, nonprostanoid, prostacyclin receptor agonist that is being developed by Actelion Pharmaceuticals Ltd and Nippon Shinyaku. | selexipag | prostaglandin I2 receptor | Homo sapiens |